Results 231 to 240 of about 83,111 (274)

Extracorporeal Membrane Oxygenation

Pediatric Clinics of North America, 1994
Extracorporeal membrane oxygenation has now evolved into standard therapy for patients unresponsive to conventional ventilatory and pharmacological support. This article presents a clinical review of extracorporeal life support and its application to neonatal and pediatric patients as well as children requiring circulatory support after open heart ...
M D, Klein, G C, Whittlesey
openaire   +2 more sources

EXTRACORPOREAL MEMBRANE OXYGENATION

Nursing Clinics of North America, 1997
Extracorporeal membrane oxygenation (ECMO) is prolonged cardiopulmonary bypass used to treat critically ill patients with severe but reversible cardiac and/or respiratory failure. The severity of their symptoms, the rapid deterioration in their conditions, the difficulty in mechanical transportation, and the risks of traveling with an ECMO circuit ...
E A, Caron, J L, Hamblet Berlandi
openaire   +2 more sources

Extracorporeal Membrane Oxygenation

Emergency Medicine Clinics of North America, 2008
ECMO is an important tool to provide oxygen delivery and carbon dioxide removal in addition to cardiac support for patients with intractable reversible respiratory or cardiovascular collapse unresponsive to conventional treatment. Even though ECMO can be a life-saving modality, it is expensive and labor-intensive and carries a significant complication ...
Onsy, Ayad, Ann, Dietrich, Leslie, Mihalov   +2 more
openaire   +2 more sources

Extracorporeal membrane oxygenation

Medical Journal of Australia, 2009
Extracorporeal membrane oxygenation (ECMO) is a technique that involves oxygenation of blood outside the body, and provides support to selected patients with severe respiratory or cardiac failure. The two major ECMO modalities are venoarterial and venovenous.
Steven J, Lindstrom, Vincent A, Pellegrino, W Warwick, Butt   +2 more
openaire   +2 more sources

Argatroban in Extracorporeal Membrane Oxygenation

Artificial Organs, 2007
Abstract:  The objective of this study was to assess the required dose and anticoagulatory effect of argatroban (Mitsubishi, Pharma Deutschland GmbH, Düsseldorf, Germany), a direct thrombin inhibitor approved for anticoagulation in patients with heparin‐induced thrombocytopenia (HIT) undergoing extracorporeal membrane oxygenation (ECMO).
Martin, Beiderlinden, Tanja, Treschan, Klaus, Görlinger, Jürgen, Peters   +3 more
openaire   +2 more sources

Echocardiography for extracorporeal membrane oxygenation

Echocardiography, 2022
AbstractExtracorporeal membrane oxygenation (ECMO) provides advanced cardiopulmonary life support for patients in cardiac and/or respiratory failure. Echocardiography provides essential diagnostic and anatomic information prior to ECMO initiation, allows for safe and efficient ECMO cannula positioning, guides optimization of flow, provides a modality ...
Patrick T. Hussey, Gregory von Mering, Navin C. Nanda, Mustafa I. Ahmed, Dylan R. Addis   +4 more
openaire   +2 more sources

Extracorporeal Membrane Oxygenation in the NICU

Neonatal Network, 2015
ABSTRACTExtracorporeal membrane oxygenation (ECMO) was developed for adults but has been used in neonates as a life-saving rescue therapy for infants with respiratory failure and/or cardiac collapse as a result of congenital diaphragmatic hernia, meconium aspiration syndrome, persistent pulmonary hypertension, or systemic sepsis.
Kelli Beckvermit, Prine, Kimberly, Goracke, Lori Baas, Rubarth   +2 more
openaire   +2 more sources

Pediatric Extracorporeal Membrane Oxygenation

Critical Care Clinics, 2017
Extracorporeal life support is a modified form of cardiopulmonary bypass. Experience in extracorporeal membrane oxygenation (ECMO) has come largely from the neonatal population. Most centers have transitioned the ECMO pumps from roller pumps to centrifugal technology.
Christopher Loren, Jenks, Lakshmi, Raman, Heidi J, Dalton   +2 more
openaire   +2 more sources

Extracorporeal Membrane Oxygenation in the Newborn

Military Medicine, 1990
Extracorporeal membrane oxygenation (ECMO) is used in the treatment of reversible pulmonary disease in the newborn. The ECMO program at Wilford Hall USAF Medical Center began in 1985 and to date, 57 patients have been placed on bypass for a mean of 125 hours.
K P, Lally, R, Clark, C, Schwendeman, S, Harrell, B, Yoder, J, Carter, D, Null   +6 more
openaire   +2 more sources

Mobile extracorporeal membrane oxygenation

The Annals of Thoracic Surgery, 1993
Transport of critically ill neonates in need of extracorporeal membrane oxygenation can be risky. Their extreme cardiorespiratory instability may delay or even preclude conventional transport to an extracorporeal membrane oxygenation center. We report the use of a UH-1 helicopter specially adapted for mobile extracorporeal membrane oxygenation support ...
S C, Faulkner, B J, Taylor, C W, Chipman, L L, Baker, J W, Fasules, S H, Van DeVanter, J E, Harrell   +6 more
openaire   +2 more sources